On July 18, #CFX# , the stock price of Navigator Pharma Biotech (HK00399) listed on the Hong Kong Stock Exchange rose by 23%. It is noteworthy that Navigator Pharma Biotech had previously announced plans for a full acquisition of the blockchain project Conflux, aiming to expand its blockchain business. Currently, two founding members of Conflux have taken on executive director roles at Navigator Pharma Biotech.

CFX14.02%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)